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In certain New World monkeys Epstein-Barr (EB)  1 viral infection is accompanied by 
the  development of lymphoproliferative disease.  Four  of eight  cotton-top marmosets 
(tamarins) inoculated with Epstein-Barr virus (EBV) (the Hawley strain) derived from a 
patient with post-transfusion heterophile-positive mononucleosis, developed malignant 
lymphoma (1). The EB3 Burkitt lymphoma virus strain induced malignant lymphoprolifo 
erative disease in an owl monkey, and a  cell line recovered from this tumor contained 
viral DNA (2, 3). Another mononucleosis strain ofEBV, Kaplan, was subsequently found 
to induce  lymphosarcoma in  cotton-top marmosets  (4). The likelihood that EBV was 
etiologically responsible for the lesions was increased by the demonstration of the EB 
nuclear antigen in the majority of cells of an imprint prepared from a tumor biopsy (5). 
Additional evidence for the  etiologic role of EBV was the demonstration of the EBV 
genome directly in  tumor cell  DNA by the  technique of molecular hybridization (6). 
Finally, in vivo neutralization tests done on small scale demonstrated that leukoviremia 
and mesenteric adenopathy could be prevented by preincubation of the inoculum with 
EBV antibody-positive human serum and not by incubation with antibody-free human 
serum (7). 
The present report describes results of inoculations of a larger group of cotton- 
top marmosets with EBV and delineates the spectrum of histiologic responses. 
Particular emphasis was placed on attempts to demonstrate EB virus and viral 
DNA in the pathologically involved lymph nodes and to characterize biologic 
and antigenic properties of virus obtained from the experimental lesions. 
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TABLE  I 
Summary of Inocula 
949 
Transforming 
Exp.  Description of inoculum  tAter/0.2  ml  Volume 
ml 
Autologous EBV-converted cells (1-3  x  108 cells)*  NA  1.0 
Cell-free EBV; B95-8 strain; E68 stocks  103T  1.0 
EBV from throat washing -  Marmoset adapted  10  ~'5  1.0 
-  Direct from patient§  10  z'2  1.0 
EBV from cloned cells; F-12 clone 29  102"s  3.0 
Cell-free EBV; B95-8 strain; K41 stockll  103"s  5.0 
Cell-free EBV; B95-8 strain; K86 stock¶  1043  8.5 
Cell-free EBV; L39-2 stock**  104"~  5.5 
* Reference i. 
S Reference 8. 
§ Reference 9. 
I[  Passed in vitro for ii mo. 
¶ Cells revived from freezer after 13 too. 
** From a cell  line  obtained from a tumor of  animal 667 in experiment 5. 
Methods 
Marmosets.  Wild cotton-topped tamarins, Saguinus oedipus, were a mixture of  juveniles and 
adults,  males  and females.  They were regularly  infected with two parasites,  microfilaria and 
burrowing acanthocephalid nematodes, Prosthenorcis elegans, found in the terminal small intes- 
tine.  Death from intestinal perforation,  peritonitis, and abscess formation due to Prosthenorcis 
occurred in several animals before inoculation with EBV. During observation of several months to 
3  yr certain  animals  developed clinical and  radiologic evidence of pathologic fractures  which 
responded to treatment with vitamin D and ultraviolet light. 
EBV and Control lnocula.  Several different types  of EBV inocula,  listed in Table I,  were 
employed in seven experiments  involving 20 animals.  Inocula were filtered through  a  0.8  /~m 
Millipore filter and were shown to contain biologically active EBV as determined by the assay 
based on immortalization of human umbilical cord leukocytes (8). The virus tAter ranged from 10  zs 
to 1043 TDso/0.2 ml. 16 animals (experiments 1, 2, 4-7) received the Hawley strain (8). The other 
four animals received virus from throat washings of two other patients, one with mononucleosis 
and one an inapparent excretor who was an immunosuppressed renal transplant recipient (9). 
Six uninoculated and four mock-inoculated animals were observed in parallel with inoculated 
animals. Two of these received spent medium from the "Raji" Burkitt lymphoma line which does 
not  contain  EB virions; one  animal  received extracellular  fluid from the  "P3J-HR-I" Burkitt 
lymphoma line which contained EB virions biologically active only when measured by induction of 
early antigen in nonproducer  human  lymphoblastoid cell lines and  inactive by transformation 
(10).  A  fourth animal received fresh tissue culture medium RPMI 1640 supplemented with fetal 
calf serum and antibiotics. 
Each inoculation was made on a  single day by a  combination of the intravenous,  intraperito- 
heal, and intramuscular routes. One animal (experiment 6) was also given EBV by means of spray 
into the pharynx. 
Assays  for EB Virus.  The number  of viral particles was estimated  by electron microscope 
counts of negatively stained preparations concentrated 100-fold  by ultracentrifugation  (11). Bio- 
logically active virus was  measured  by  morphologic transformation  of human  umbilical cord 
leukocytes  (8).  Virus  of the transforming  biotype  was  also  measured  by stimulation  of DNA 
synthesis  in human  umbilical cord  leukocytes,  as judged by the incorporation of [aH]Tdr (12). 
Virus from the P~J-HR-1 line of Burkitt lymphoma cells was assayed by the appearance of "early 
antigen" (EA) in superinfected Raji cells. The number of EA-positive cells was determined 3 days 
aider addition of virus, by indirect immunofluorescence using an anti-EA positive human refer- 
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Derivation  of Cell Lines.  Leukocytes from heparinized  peripheral  blood were separated  by 
addition of dextran at a  final concentration of 2%,  and the leukocytes were placed in stoppered 
tubes at a concentration of 1-2 ×  106/ml. Cell lines from spleen and lymph nodes were established 
by placing minced fragments in a tube with medium. Alternatively, the fragments were placed on 
a 2-cm circle ofteabag paper atop stainless steel grids. The grid was put in 3 ml of medium in a 35- 
mm Petri dish which was incubated in a humidified atmosphere of 5% CO2 and air. 
Detection of  EBV-Associated Antigens in Lymph Nodes and in Cell Lines.  Two antigens were 
sought, the viral capsid antigen (VCA) and the EB nuclear antigen (EBNA). Reference human 
sera with and without anti-VCA and anti-EBNA were used. The techniques of indirect immuno- 
fluorescence (14) and of anti-complement immunofluorescence (15) were employed. 
Detection  of EBV DNA.  Tumors were tested by the technique of DNA/DNA reassociation. 
Cellular DNA was extracted from tumor tissues (16), EBV DNA was isolated from P3HR-1  virus 
particles, purified by centrifugation in CsC1, and labeled in vitro by the nick-repair method (17). 
Reasseciation kinetics were performed as described previously (18). 
The method of cRNA/DNA membrane hybridization was used to test for the presence of the 
EBV genome in cell lines. 3H-cRNA with asp act of about  l0  s cpm per ~g was prepared from a 
template of purified P~-HR-1 viral DNA (18). 50 ~g of total DNA from the marmoset cell lines was 
applied to duplicate filters. The background  of hybridization between cRNA and cellular DNA 
from HEp2 cells was subtracted. The number of genomes present in the lines was calculated with 
reference to a standard  of hybridization with DNA from the Raji line which contains 60 genome 
equivalents per cell. 
Antibodies  to  Viral  Capsid  and Early Antigens.  Antibodies  to  viral  capsid  antigen  were 
measured  by  indirect  immunofluorescence  with  fluorescein-conjugated  anti-rhesus  monkey 
gamma globulin prepared in a goat. (Antibodies, Inc., Davis, Calif.). The antigen was present in 
two EB virus producer lines, B95-8 and P~-HRol; sera simultaneously titered on the two cell lines 
demonstrated equivalent titers. Antibodies to early antigen were measured by reaction with Raji 
cells which had been superinfected by P3J-HR°I virus. 
Neutralizing Antibodies.  Virus-neutralizing antibodies were determined by the technique of 
inhibition of stimulation of DNA synthesis  (19).  Antibodies were measured against three EBV 
strains,  the  homologous strain  with  which  the  animals  were  inoculated  and  two  BL-derived 
strains. 
Results 
Incidence of Lesions  (Table II).  6 of 20 animals developed large tumors of 
mesenteric lymph nodes. In three instances the tumors were highly necrotic. In 
three instances  (642, 655,  667) the cytology was well preserved and resembled 
diffuse malignant  lymphoma of the reticulum  cell  or immunoblastic  type of 
man.  One animal  (656) developed extensive lymphoreticular hyperplasia evi- 
dent at the autopsy performed when the animal was moribund.  In two other 
animals  (650, 644) there was extensive lymphoreticular hyperplasia in mesen- 
teric lymph nodes removed by surgical biopsy 8 wk after inoculation; however, 
these lesions regressed. At autopsy 9 and 18 mo after inoculation, respectively, 
the lymph nodes were normal.  Seven marmosets demonstrated no pathologic 
evidence  of lymphoproliferative  disease  at  autopsies  17  wk  to  22  mo  after 
inoculation.  One animal died 8 days after inoculation from abscess formation, 
intestinal perforation, and peritonitis due to Prosthenorcis.  Three animals are 
still living and show no evidence of disease. 
Of six animals that developed malignant lymphoma, one received autologous 
EBV-converted cells and five received cell-free virus.  Four of the six animals 
with tumors had received immunosuppressive drugs. Lymphoma was observed 
in an animal given virus obtained from a single cell clone. Transient hyperpla- 
sia was observed in one of two animals  given  EBV obtained directly from a 
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TABLE II 
A Listing of 20 Cotton-Top Marmosets Inoculated  With Transforming  EB Virus 
Exp. 
Immunosup- 
pressive drugs  Duration of  ob-  Maximum  Maximum 
Animal no.  Before  After  servation after  EB virus re-  Histologic result (lymph 
inoc-  inoc-  inoculation  covery (wk)*  antibody ti-  antibody ti-  ter to VCA  ter to EA  nodes) 
ula-  ula- 
tion  tion 
1  625  3  21  32 wk  640  160  Necrotic tumors 
626  0  0  17 wk  ND  80  <i0  Normal 
621  3  21  45 wk  40  20  Normal 
623  0  0  36 mo  80  80  Normal 
2  639  3  21  31 days  -  <5  ND  Necrotic tumors 
641  3  21  34 days  -  <5  ND  Necrotic tumors 
640  0  0  22 mo  20  5  Normal§ 
642  0  0  49 days  +  (7)  20  5  Immunoblastic lymphoma 
3  645  3  0  74 days  10  ND  Normal 
646  3  0  8 days  <10  ND  Abscess 
649  3  0  >28 mo  -  <10  ND  Not done (living) 
650  3  0  9 mo  20  ND  Hyperplasia][ 
4  654  0  0  16 mo  20  <5  Normal 
655  0  0  49 days  +  (7)  <10  <5  Immunoblastic lymphoma 
5  643  0  0  17 mo  -  <10  <5  Normal 
644  0  0  18 mo  +  (9)  20  <5  Hyperplasia~l 
667  3  14  57 days  +  (8, 9)  80  80  Immunoblastic lymphoma 
668  3  14  >24 mo  ND  20  <5  Not done  (living) 
6  656  0  0  38 days  + (6)  80  <5  Extensive  hyperplasia¶ 
7  671  2  21  >19 mo  +  (3, 4, 5)  40  5  Not done (living) 
* After inoculation. 
$ Animal died. 
§ Enlarged abdominal lymph nodes observed by palpation. 
II Hyperplasia  present at biopsy approximately 2 mo aRer inoculation but not at autopsy. 
¶ Present at autopsy when a moribund animal was sacrificed. 
The entire spectrum of pathologic responses including no infection, inappar- 
ent infection (development of antibodies only), transient hyperplasia, and ma- 
lignant lymphoma occurred in experiment 5 in which four animals received the 
identical inoculum. 
6 of 10 uninoculated or mock inoculated animals were autopsied. All failed to 
demonstrate lymphoreticular lesions. None developed antibodies and no virus 
was recovered from their lymph nodes, spleen, or peripheral blood.  Of the 10 
control marmosets 4 had received 3 wk therapy with immunosuppressive drugs. 
Histological Findings by Light Microscopy.  In uninoculated animals or in 
those that remained normal after inoculation, the lymph nodes were small, with 
well-defined germinal centers and interfollicular zones  (Fig.  1).  The follicles 
contained few cells in mitotic division. The borders of the follicles were crowded 
with closely packed small lymphocytes. In an occasional animal, irregularity of 
follicle size and confluence of interfollicular lymphoid accumulations indicated 
mild focal hyperplasia which was not considered abnormal. 
Hyperplasia of a pronounced degree was a prominent finding in the lymph 
nodes of three inoculated animals (Fig.  2).  This change varied from a  slight 
increase in size and irregularity of germinal centers with increase and crowding 
of lymphocytes in focal areas of nodes, to massive confluence of follicles with 952  INOCULATIONS  OF  COTTON-TOP  MARMOSETS  WITH  EBV 
FIG.  1.  Histology of normal marmoset lymph nodes: (marmoset no. 645):  (a)  ×  40,  (b) × 
250. The nodes are small (<5 mm). The well-defined follicles contain many cells with large, 
clear nuclei (b). The nuclear membranes of the follicle cells are thick, and distinct nucleoli 
are present. Most of the nuclei are uncleaved. Some mitotic figures are present. Cytoplas- 
mic borders are indistinct. The follicles are surrounded by dense masses of mature lympho- 
cytes with uniform, densely stained nuclei and scanty cytoplasm (a). Occasional large, pale 
phagocytes are present in the follicles and surrounding tissue. 
abundant mitotic figures, accompanied by dense lymphocytic cellularity of the 
interfollicular zones. Mitoses were present in the latter areas as well as numer- 
ous small foci of large reticular of histiocytic cells giving rise to a "starry sky" 
appearance.  Although occasionally such  changes  suggested the  histological 
appearance of malignancy, uniformity of cellular and nuclear size and shape 
and some preservation of node architecture made such an interpretation un- 
likely. Normal, hyperplastic and even malignant lymphoid nodules in the same 
animal were not uncommon (Fig.  3).  In the germinal centers of hyperplastic 
nodes the predominant cells exhibited large, vesicular, uncleaved nuclei. Mi- 
totic figures were abundant. 
In the six animals with tumors, the gross lesions presented as nodules, 0.5-2.0 
cm  in  diameter,  in  the  mesenteries of the  small  intestines.  Some of these 
nodules were in close proximity to the gut and were locally invasive (Fig.  4). 
Histologically the tumor masses were often partially or totally necrotic. Where 
the tissues were preserved the component cells were arranged in irregular cords 
and masses, obliterating the basic lymph node architecture. (Figs. 4 and 5). The 
replacement  of  nodal architecture occurred through enlargement and confluence 
of follicular structures. Nodes with marked follicular and interfollicular hyper- 
plasia were present along with the definitely malignant tumor nodules. Acute 
inflammatory changes consisting of edema, hemorrhage, and accumulations of 
polymorphonuclear leukocytes were also observed in several sections of tumor. 
In one animal, with inflammatory  tissue changes and hyperplastic nodes, cross- 
sections of a parasitic nematode were observed. 
The tumor cells were arranged without polarization or organoid structure. 
The majority were large, polygonal in shape, with abundant cytoplasm and with MILLER,  SHOPE,  COOPE,  WATERS,  PAGANO,  BORNKAMM,  AND  HENLE  953 
Fro.  2.  Histology ofhyperplastic marmoset lymph nodes (marmoset no. 650): (a) × 40, (b) 
x  250. The nodes are enlarged (10-15 ram) and congested. There is increase in number, size, 
and irregularity of  follicles. Follicular cells have large vesicular, predominantly uncleaved, 
nuclei (b).  Nucleoli are oiten present.  Mitoses are frequent. In the interfol]icular regions 
there are, besides the masses of small lymphocytes, many large nucleated cells similar to 
the large cells of the follicles. The architecture of the node is intact, with an intact capsule. 
FIG.  3.  Histology of lymph nodes with combined hyperplasia  and lymphoma (marmoset 
no.  655):  (a)  x  40,  (b)  x  250.  The  nodes  are  intensely  hyperplastic  with  large  cortical 
follicles and  crowding of interfollicular lymphocytes  (a).  In other nodules  the follicular 
structure of the node is lost and is replaced by diffuse masses of cells with large vesicular 
nuclei (b). There are a fair number of  even larger cells with cleaved or partitioned nuclei. 
large irregular nuclei. The nuclei always contained one or more clearly observed 
nucleoli. They were predominantly uncleaved. Mitotic figures were plentiful in 
all  tumors.  Admixture  of small  and  medium-sized lymphocytes in  varying 
numbers was present.  Large, clear cells of macrophage type were often found 
scattered through intensely hyperplastic interfollicular areas. 954  INOCULATIONS  OF  COTTON-TOP  MARMOSETS  WITH  EBV 
FIG.  4.  Histology of lymph nodes with malignant lymphoma (marmoset no. 642): (a and b) 
x  40,  (c)  x  100,  and  (d),  ×  1,000.  A  nodule  involving the  bowel  wall  is  shown  (a). 
Interspersed among zones of coagulation necrosis  (b) are solid cores of large,  irregularly 
shaped cells showing little orientation (c). These cells have abundant cytoplasms and large, 
irregular  nuclei  with prominent  nucleoli  (d).  Their cytoplasmic borders  form  a  mosaic 
pattern. Mitotic figures are abundant,  some with abnormal configurations. There are a fair 
number of cleaved, or folded, nuclei, but these comprise a  minority of those present. 
Ultrastructure  of Tumor  Cells  (Fig.  6).  Two  types  of cells  different in 
nuclear and cytoplasmic detail were found in the lymphoma of one marmoset 
(642). The nucleus of one cell type (Fig. 6a and b) had prominent heterochroma- 
tin and nuclear pores; whereas there was sparse heterochromatin and few pores 
in the nucleus of the other cell type (Fig. 6 c and d). Many of the features of the 
cell with coarse heterochromatin were preserved in cell lines cultivated in vitro 
from the tumors. 
Antibody Responses 
A~rrIBODIES TO VIRAL CAPSID ANTIGEN (FIG. 7).  Of 20  animals given trans- 
forming EBV 14 developed antibodies to VCA. Four of the six animals without MILLER,  SHOPE,  COOPE,  WATERS,  PAGANO,  BORNKAMM,  AND  HENLE  955 
FIG.  5.  Histology of diffuse  malignant  lymphoma  compatible with  immunoblastic  sar- 
coma (marmoset no. 667): (a and b) × 40, (c) x  250, and (d) x  1,000. An encapsulated nodule 
in the mesentery is devoid of normal lymph node structure (a). It contains diffuse masses of 
large lymphoid cells. Areas of  the node display a "starry sky" appearance (b). The masses of 
tumor cells are closely packed without orientation.  Individual cells have large, vesicular 
nuclei with prominent nucleoli (c and d). Some nuclei have a plasmacyteid arrangement of 
chromatin.  There  are  scattered  mitotic figures.  The  majority of the  cell nuclei are  un- 
cleaved, though irregular. 
detectable anti-VCA died or were sacrificed within the first 7 wk after inocula- 
tion; of these seronegative animals which died early, three had tumors and one 
had  an  abscess. The  remaining  two seronegative  animals  survived for many 
months and failed to develop clinical or pathologic signs of lymph node disease. 
They presumably were never infected by the virus. 
Antibodies were first detected about 2-3 wk after inoculation of autologous 
cells and from 4 to 12 wk al~er inoculation of cell-free virus (5). Once anti-VCA 
appeared in the serum it persisted thereafter for the remainder of the observa- 
tion period. In only one instance was a significant change in titer observed. An 956  INOCULATIONS  OF  COTTON-TOP  MARMOSETS  WITH  EBV 
animal subsequently found to have lymphoma showed a rise in antibody titer 
between the 3rd and 6th mo after inoculation. 
The maximum titer of anti-VCA was higher in animals given autologous 
EBV-converted cells than in those given cell-free virus (Fig. 7). The animal that MILLER,  SHOPE,  COOPE,  WATERS,  PAGANO,  BORNKAMM,  AND  HENLE  957 
developed lymphoma after injection of autologous cells demonstrated the high- 
est anti-VCA titer (1:640). Among the group given virus the two highest anti- 
VCA titers were observed in animals that developed lymphoma or extensive 
hyperplasia. 
ANTIBODIES  TO  EARLY  ANTIGEN  AND  EB  NUCLEAR  ANTIGEN.  Sera from 14 
marmosets were tested for antibody to "early antigen" at the time when anti- 
VCA was maximum. Three of four animals inoculated with cells showed anti- 
EA; the highest anti-EA titer was seen in the animal with lymphoma. Among 
marmosets given cell-free virus, only one animal, which developed lyrnphoma, 
had a  high anti-EA titer. The antibodies observed were directed against the 
diffuse D component of  the early antigen. A low level of antibedy to EBNA (1:10) 
was detected only in one animal with lymphoma (no. 667). 
NEUTRALIZING ANTIBODY.  Preinoculation and late postinoculation sera of 
two animals were tested for their ability to inhibit stimulation of DNA synthesis 
by three transforming strains of EBV (Fig.  8). Preinoculation serum failed to 
neutralize either the Hawley EBV strain with which the animals were inocu- 
lated or two  other virus  strains from Burkitt lymphoma. One animal with 
inapparent infection and a  moderate anti-VCA antibody response developed 
neutralizing antibodies against the Hawley strain and the Olare strain.  The 
other animal with lymphoma and a high anti-VCA titer developed neutralizing 
antibodies to all three strains.  When preillness serum from the animal with 
lymphoma was mixed with the three viruses, the extent of DNA stimulation by 
the viruses was comparable to that produced by their admixture with human 
antibody-negative serum or with medium (Fig.  8).  Late  convalescent serum 
obtained 224 days after inoculation produced about a 100-fold inhibition of DNA 
stimulation by the Nyevu (BL) virus, about a 10-fold reduction in stimulation of 
DNA synthesis by the Olare (BL) virus, and a 10,000-fold reduction in stimula- 
tion of DNA synthesis by the homologous virus (Hawley) with which the animal 
was inoculated. 
Recovery of and Characterization of Virus 
DIRECT EXAMINATION  OF LYMPH NODES.  We failed to detect virus particles in 
thin sections of lymph nodes from three animals with lymphoma  and one control 
animal. Imprint smears prepared from five lymph nodes, three with lymphoma 
and two with hyperplasia, did not show evidence of viral capsid antigen. EB 
nuclear antigen was seen in 100% of cells of one lymphoma and in a  smaller 
proportion of cells from a node with hyperplasia (Fig.  9). 
EBV DNA IN TUMORS.  EBV DNA was detected in lymphomas of three ani- 
mals.  (Table IV).  It was found in both a  biopsy and autopsy specimen from 
Fro.  6.  Ultrastructure of cells found in lymphoma of CTM 642.  Two types of cells were 
found. The nucleus of the cell type shown in (a) and (b) has dense chromatin and nuclear 
pores are easily recognized (arrowheads). There are both free ribosomes and sparse rough 
endoplasmic reticulum.  The surface of the cells is highly elaborated with microvilli and 
pseudopods. Neither Golgi apparatus nor lysosomes are prominent. Cells are surrounded by 
a matrix of collagen. The cells in (c) and (d) have distinctly different nuclear and cytoplas- 
mic characteristics. The chromatin is dispersed and noncondensed, and few nuclear pores 
are identified. The cytoplasm has few free ribosomes; instead there is massive elaboration of 
rough endoplasmic reticulum. The channels (d) appear swollen with a  granular material. 
Microvilli formation is not as prominent as in cells shown in (a) and (b). Bars represent 1 
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FIG. 7.  Maximum  antibody titers  to EB VCA  and EA in inoculated marmosets with 
different histologic  responses. (0) anti-VCA; (O) anti-EA. 
one animal (642). There were approximately 8-30 genome equivalents of EBV 
DNA per cell. A barely detectable level of EBV DNA (about three genomes/cell) 
was found in the lymph node of an animal with hyperplasia. No EBV DNA was 
detected in a lymph node from an animal (646) that died of an abscess. 
CELL LINES.  Lymphoblastoid lines were established from mesenteric lymph 
nodes, spleen, mediastinal lymph nodes, or blood leukocytes of six animals from 
3 to 9 wk after inoculation (Table III). In one instance a virus shedding line was 
recovered from an animal (no. 655) that never developed detectable antibodies to 
VCA. All but one of the lines produced virus. About 5-10%  of the cells made 
viral capsid antigen. Typical EBV-herpes virions were found in 100-fold concen- 
trated extracellular fluids from the three lines studied. A total of  eight cell lines 
from five animals were found to release biologically active extracellular EBV 
with titers of 1,000-30,000  transforming units per 0.2 ml. All viable cells in each 
line contained EBNA. 
CYTOLOGIC FEATURES OF CELL LINES DERIVED FROM TUMORS.  The cell lines 
adhered loosely to glass and plastic. Receptors for serum complement (EAC') or 
the  Fc  fragment of IgG  (EA-7S)  were  not  detectable  in  a  cell  line  from  a 
marmoset tumor (20). 
LEUKOCYTE-ASSOCIATED  VIREMIA.  Continuous  lymphoblasteid  cell  lines 
were derived from peripheral blood leukocyte cultures of two animals, one with 
hyperplasia in the 9th wk after inoculation and one with inapparent infection in 
the 3rd through 5th wk after inoculation. In the latter instance (see Fig. 10) cell 
lines were not obtained after the 5th wk. Antibody to viral capsid antigen was MILLER,  SHOPE,  COOPE,  WATERS,  PAGANO,  BORNKAMM,  AND  HENLE  959 
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Fro.  8.  Neutralizing antibody to three EBV strains in a marmoset (no. 625) which devel- 
oped lymphoma. Antibody was detected by ability of serum to inhibit stimulation of DNA 
synthesis by the viruses. (- -  -) pre-inoculation serum. (--) serum day 224 after inoculation. 
Virus strains:  (J) Hawley (IM), the strain given to the animal,  (©) Nyevu (BL) and (A) 
Olare (BL). The background of spontaneous DNA synthesis in umbilical cord  leukocytes 
unexposed to virus was first subtracted. Uninfected cord cells exposed to medium 157 cpm, 
to preinoculation serum  131  cpm,  to day  224  serum  204 cpm,  and to  antibody-negative 
human serum 224 cpm. 
not detected until the  12th wk after inoculation. In this experiment another 
marmoset given an equal number of virions from the nontransforming  P3J-HR-1 
virus strain failed to develop leukoviremia or antiviral antibodies. 
EBV-DNA IN CELL LINES (TABLE IV).  EBV DNA was found in two cell lines 
derived from lymphomateus nodes placed in culture 7 and 9 wk after inocula- 
tion, respectively. The amount of hybridization indicated an "average" of 140 
and 205  genome equivalents per cell, a  finding consistent with both cell lines 
being virus producers. 
NEUTRALIZATION OF VIRUSES RELEASED FROM TWO LYMPHOMA  CELL  LINES.  In 
one experiment the ability  of antibody-positive  and antibody-negative  human 
sera to neutralize morphologic transformation was measured. In a second exper- 
iment the ability of such sera to inhibit stimulation of DNA synthesis in human 
umbilical cord blood leukocytes was examined. In both experiments the viruses 
obtained from the  lymphomas were neutralized by antibody-positive human 
sera and not by antibody-negative human sera (Table V). 960  INOCULATIONS  OF  COTTON-TOP  MARMOSETS  WITH  EBV 
Fro.  9.  EB nuclear  antigen  in  direct imprint of lymph node  from marmoset 667  with 
lymphoma. 
TABLE  III 
Establishment of Cell Lines from Inoculated Animals and Demonstration of EBV in 
Extracellular Fluids 
Extracellular  EB virions re- 
leased from cell lines 
Weeks after inoc-  Transforming 
Ani-mal  Exp.  Diagnosis  Sources of cell  lines  ulation  when cell  NO.cles/mlParti-of  titer/0.2 rnl of 
line was obtained  100 x  con-  unconcen- 
trated super- 
centrate 
natant  fluid 
642  2  Lymphoma  Mesenteric node; spleen  7 
655  4  Lymphoma  Mesenteric node (biopsy)  7  ~i'i)  2-~ 
644  5  Hyperplasia  Mesenteric  node  ~biopsy);  9  3 x  10  ~  10  ~ ~ 
peripheral blood 
667  5  Lymphoma  Mesenteric  node (biopsy  and  8, 9  2 x 108  I04  o, I0<O, 
autopsy); rnediastinal node  104~, 10  ~-~ 
656  6  Extensive  hy-  Mesenteric node; spleen  6  5 x  10  R  ND 
perplasia 
671  7  Inapparent in-  Peripheral blood  3, 4, 5  104'°, 10  <~ 
fection 
Discussion 
Parallels Between Experimental and Human Infection.  The lymph nodes of 
cotton-top  marmosets  inoculated  with  EBV  are  the  seat  of lymphoreticular 
proliferations ranging from mild to intense hyperplasia and in six instances to 
definite lymphoma formation. The tumors,  on the basis of their predominant 
cellular characteristics,  would formerly have been classified as reticulum cell 
or histiocytic lymphomas. However, recent advances have stressed the probabil- 
ity  that  immunologically  or virally  transformed  lymphoid  cells  of follicular 
origin are involved in lymphoma formation. Composed mainly of large polygo- 
nal cells with oval vesicular, uncleaved nuclei, with distinct nucleoli and with MILLER,  SHOPE,  COOPE,  WATERS,  PAGANO~  BORNKAMM,  AND  HENLE  961 
TABLE  IV 
Demonstration of EBV DNA in Lymph Nodes and in Cell Lines of EBV-Inoculated 
Cotton-Top  Marmosets 
In lymph nodes*  In cell lines$ 
EBV  cpm 3H-  EBV 
Ani-  cRNA 
mal  genome  Ani-  hybrid-  genome 
Histologic diagnosis  equiva-  mal  Histologic diagnosis  ized/50  equiva- 
lents]  lents/ 
cell  ~g cell  cell 
DNA§ 
625  Lymphoma (necrotic)  30 
639  Lymphoma (necrotic)  30 
642  Lymphoma  (immu-  8; 1011 
noblastic) 
656  Hyperplasia  3 
646  Normal  0 
655  Lymphoma  (immu-  4,377  140 
noblastic) 
667  Lymphoma  (immu-  7,356  205 
noblastic) 
* Technique of DNA/DNA reassociation. 
$ Technique of cRNA/DNA membrane hybridization. 
§ The cpm hybridized to 50 ~g HEp2 DNA was 430; to 50 ~g Raji cell DNA 2,206. 
I[ One determination on a biopsy, one on an autopsy 1 mo apart. 
abundant cytoplasm, these tumors would fit either the large, uncleaved follicu- 
lar lymphoma or the immunoblastic sarcoma categories of human lymphomas 
as  classified by Lukes and Collins  (21). The presence in  some areas of the 
involved nodes of intense lymphoid hyperplasia with scattered "reactive" phago- 
cytes simulates a histologic pattern found in Burkitt's lymphoma in man. 
Several aspects of the pathogenesis of the experimental infection of marmo- 
sets mimics natural infection of man by EBV. Infection of the marmoset results 
in permanent acquisition of antibodies that persist for the remainder of the life 
of the animal. Virus can be readily recovered from blood leukocytes of infected 
animals for several weeks after inoculation and from lymph nodes as late as 9 
wk after inoculation. These findings are compatible with continued viral persist- 
ence after the initial infection. 
Virus particles are not found in the marmoset tumors per se which nonethe- 
less contain the EBV nuclear antigen and the EBV genome. Once the tumor 
cells are placed in culture, mature EBV is found in the cells which proliferate in 
vitro. This finding is analogous to Burkitt lymphoma. Viral DNA and EBNA 
are found directly in tumor biopsies and mature virus in the derivative cell lines 
(22). 
An additional parallel with human infections is that marmosets with lym- 
phoma and hyperplasia had higher anti-VCA and anti-EA titers than those 
whose infections were clinically inapparent (23). This finding presumably re- 
flects a larger number of virus-infected cells in the tumor-bearing individuals. 
The  more  rapid  appearance  and  higher titer  of anti-viral  antibodies  after 
injection of transformed cells than after virus also probably reflects a  larger 
antigenic mass. 
Some differences between infection of humans and marmosets with EBV are 962  INOCULATIONS  OF  COTTON-TOP  MARMOSETS  WITH  EBV 
ANTIBODY 
TO  V.C.A. 
RECOVERY  OF 
CELL  LINE 
FROM  BLOOD 
MARMOSET  671 
INOCULUM:  L59-2~  105  IOso/ml 
I.V. •  2.Oral 
I.P.  :  5.Oral 
I.M.  ffi 0.5ml 
40 ~  QP-H 
f 
B95 
10 
<10 
I  I  I  I 
-+  ++ 
%'///4'/,°/,°/,  %  %%  % 
I  I  I  I 
MARMOSET  672 
INOCULUM:  PsHR-I 
I.V.  •  2.5  ml 
I.P,  = 4.0ml 
I.M.  -  O.5ml 
4O 
ANTIBODY  20 
TO  V.C.A. 
10 
<10 
RECOVERY  OF 
CELL  LINE 
FROM  BLOOD 
P-H 
-  °  ....  B95 
l  I  I  I 
%0/0/,,%0/0/,  o/,  %%  % 
I  I  I 
4  8  12  16 
WEEKS  AFTER  INOCULATION 
FIG.  10.  Leukoviremia and development of antibody to viral capsid antigen in a marmoset 
(no.  671) which developed inapparent infection after inoculation of EBV derived from a 
marmoset lymphoma cell line. For comparison leukoviremia and anti-VCA responses failed 
to occur in a marmoset (no.  672) given the nontransforming P3J-HR-1 EBV strain. Anti- 
VCA was measured against two antigens (O) PsJ-HR-1;  (Q) B95-8. 
also notable. In the marmoset the peripheral lymphoid system is not usually 
involved. We have been unable to detect the heterophile antibody response in 
marmosets, and the anti-EBNA response is weak or absent. These important 
differences in serologic responses may reflect differences in events leading to 
detection and elimination of virus-transformed cells. The latent period between 
infection and tumor is short in the marmoset (several weeks to months) and 
longer in the case of Burkitt lymphoma. Furthermore, the ratio of lymphoma to 
infection, even in nonimmunosuppressed marmosets, is high. 
Characteristics of the Virus Found in the Tumors.  The virus identified in 
the experimentally infected marmosets is human EBV on the basis of a combi- 
nation of biochemical, antigenic, and biologic markers. All of the sequences in 
the B95-8  EB virus, which was the original inoculum for most of the experi- 
ments, have now been shown to be present in the prototype human P3HR-1 viral 
DNA by techniques of DNA reassociation kinetics, although the P3HR-1 virus MILLER, SHOPE, COOPE, WATERS, PAGANO, BORNKAMM, AND HENLE 
TABLE V 
Human Sera Neutralized EB Viruses  Released from  Cell Lines Derived from 
Experimental Lymphomas 
963 
Human 
Anti-VCA  serum 
By inhibi-  By inhibition of 
tion of im-  stimulation oirDNA 
mortaliza-  synthesis 
tion 
Virus used 
Virus used:  Human  se- 
Anti-VCA  From 
from CTM  rum 
no. 642  CTM  no.  B95-8 
667 
R.M.  80  102.7. 
L.H.  <10  nil 
R.M.  80  3205  160 
W.A.  80  160  7640 
L.H.  <10  <10  <10 
* Neutralizing index of the serum; a 1:2 dilution of serum was mixed with virus stock, undiluted, 
and diluted 10  -I  ,  10  -2  ,  and 10  -3  . 
* Reciprocal of the dilution of human  serum which caused inhibition of stimulation of DNA 
synthesis by 0.3 log or more. 
apparently contains sequences not found in B95-8 (24). Both marmoset lympho- 
mas and derivative cell lines contain the EBV genome detectable by molecular 
hybridization. The herpes-like virus derived from the tumors shares all of the 
biologic properties of the EB virus in the inoculum: it immortalizes and stimu- 
lates  cellular  DNA  synthesis  in  human  lymphocytes, and  in  one  instance 
(experiment 7) caused experimental infection (though not tumors) of marmosets 
on further passage.  The EBV recovered from the experimental lesions shows 
serologic  cross-reaction with  the  virus  inoculated in  viral  capsid  antigens, 
nuclear antigens, and viral surface antigens. 
Neutralization tests between marmoset sera and various EBV strains (Fig. 9) 
showed that antibodies developed against both mononucleosis and BL strains, 
but with greater activity against the former. Further work is needed to deter- 
mine whether sera obtained from experimentally  infected marmosets will differ- 
entiate EBV strains. 
There is no evidence  that there is a special strain of EBV which is oncogenic in 
marmosets or in man, nor has this hypothesis yet been experimentally  excluded. 
Two  mononucleosis-derived strains  (Hawley and  Kaplan)  induce malignant 
tumors in marmosets. The strain that we employed in the majority of experi- 
ments induced the entire spectrum of pathologic lesions. Virus was recovered 
from a tumor, propagated in vitro, and then returned to another marmoset that 
developed  inapparent  infection with  leukoviremia,  but  without  detectable 
lymph node enlargement. This finding suggested that a virus found in a tumor 
is not invariably oncogenic. 
One EBV strain from Burkitt lymphoma P3J-HR-1,  is incapable of inducing 
experimental disease or even infection, as evidenced  by appearance of antibodies 
in marmosets (Fig.  10) (25). Current laboratory stocks of this strain cannot cause 
transformation of human or primate cells in vitro. This finding suggests that 
cell transformation is an important early event in the pathogenesis of experi- 
mental nonhuman primate infection, as well as lymphoproliferation. 964  INOCULATIONS  OF  COTTON-TOP  MARMOSETS  WITH  EBV 
Special  Susceptibility  of  the  Cotton-Top  Marmoset  to  Viral  Oncogene- 
sis.  The cotton-top marmoset is highly susceptible to oncogenesis by herpes 
viruses from other primate species (26). Thus the tumors induced by EBV might 
be an example of "crossed species virulence." However, unlike Herpes saimiri 
EBV  is  associated with  lymphoproliferative disease in  both  its  natural and 
experimental hosts.  There are  also marked differences in  the nature of the 
experimental disease induced in the marmoset by EBV and "crossed species" 
oncogenic viruses such as Herpes saimiri. In the latter case all the inoculated 
animals develop a rapidly fatal malignant lymphoma and occasionally leuke- 
mia. EBV infection of marmosets produces a quite different picture in which the 
outcome is variable, and there is a spectrum of pathologic responses. 
Another hypothesis is that marmosets are deficient in immunologic mecha- 
nisms necessary for surveillance and elimination of virus-transformed cells.  It 
may be relevant that marmosets are chimeric twins. However, three of four 
animals given autochthonous EBV-converted cells remained normal and thus 
were able to eliminate the cells transformed in vitro. The fourth animal devel- 
oped a tumor only after a long latent period; the lesion could have been due to 
retransformation of cells in vivo by virus released from the inoculated cells. 
Marmosets develop antibodies to viral capsid antigen slowly after inoculation 
of virus (5). Some animals with lymphoma  failed to develop antibodies even 8-10 
wk after inoculation at a time when virus could be detected in lymphoid organs. 
A similar tardiness of anti-viral antibody responses has been noted in cotton-top 
marmosets inoculated with Herpes  saimiri  viruses  (27). In this  connection, 
several human families have recently been described in which failure to develop 
antibodies after primary EBV infection is accompanied by disseminated fatal 
lymphoreticuloproliferative  disease (28). 
The increased susceptibility of the marmoset may derive from special features 
of the EBV-transformed cell per se as well as from abnormal host-tumor cell 
interactions.  Unlike  human  cells  transformed in  vitro  by  EBV,  marmoset 
transformants are productive of relatively large amounts of mature extracellu- 
lar virions (8). Virus production by marmoset cells may permit virus spread and 
more extensive transformation of susceptible cells in  the experimentally in- 
fected host. 
Marmoset cells transformed in vitro or in vivo are cytologically different from 
EBV-converted human cells. Marmoset cells adhere to glass or plastic and have 
a  higher frequency of polykarocytosis than  do  EBV-converted human cells. 
Marmoset transformants,  including cell  lines  derived from malignant lym- 
phoma, express neither the receptors for complement  nor the receptors for the Fc 
fragment of immunoglobulin G; C' receptors are present on human cell lines 
(20). Cells with the C'  and Fc receptors are present in marmoset peripheral 
blood in approximately the same proportion as in human blood. These findings 
and other experimental evidence suggest that the marmoset cell loses some of  its 
B-lymphocyte surface characteristics after immortalization. Such cell surface 
differences may enhance the oncogenicity  of the transformed marmoset cells. 
Summary 
6 of 20 cotton-top tamarins (Saguinus oedipus)  inoculated with Epstein-Barr 
virus (EBV) developed diffuse malignant lymphoma resembling reticulum cell MILLER,  SHOPE,  COOPE,  WATERS,  PAGANO,  BORNKAMM,  AND  HENLE  965 
or immunoblastic sarcoma of man.  Hyperplastic lymphoreticular lesions were 
induced in three additional animals;  in two instances the hyperplastic lesions 
regressed. Inapparent infection with development of antibody occurred in eight 
animals.  In two animals there was no evidence of EBV infection.  One animal 
died in the first week after inoculation of parasitic infection. 10 animals uninoc- 
ulated  or mock-inoculated  developed neither  lymphoproliferative  disease nor 
antibody. 
The  malignant  lymphoma appeared to arise  from a  cell with an  uncleaved 
vesicular nucleus found in the center of the germinal  follicle. The prominent 
cytologic features of this  cell were extensive formation  of rough  endoplasmic 
reticulum  and  elaboration of the cytoplasmic membrane  with microvilli.  Cell 
lines derived from these tumors did not have receptors for complement, IgFc, or 
sheep erythrocytes, and the cell lines adhered to glass and plastic. 
EB  nuclear  antigen  was  found  in  imprints  of two lymph  nodes,  one  with 
lymphoma and one with hyperplasia. EB virus DNA was detected directly in the 
tumors of three animals and in cell lines from two lymphomas. Typical herpes 
virus particles were found in supernatant  fluids from cell lines obtained from 
lymph nodes with tumors and hyperplasia, as well as in lines derived from blood 
leukocytes of marmosets  with  inapparent  infection.  These virus preparations 
had the biologic property characteristic of EBV, namely, stimulation of cellular 
DNA synthesis and immortalization  of human lymphocytes. The virus derived 
from two cell lines was neutralized by reference human sera with EBV antibody 
and not by antibody-negative human sera.  The virus derived from the experi- 
mental lesions is thus indistinghishable  from human EBV. 
The  marmoset  has  enhanced  susceptibility  to  oncogenesis  by  EB  virus. 
Among identified factors which may play a role in the heightened tumorigenic- 
ity of EB virus in this  species are the increased production of virus by trans- 
formed cells and the absence of membrane receptors for complement or IgFc on 
transformed cells. 
We are grateful for help from G. W. Smith with photomicrography, from M. Lipman with electron 
microscopy, and for cheerful technical aid from S. Smith, V. Thompson, and W. Webb. 
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